Board of Directors & Leadership
Director and CEO
Aurelio Useche leverages over 20 years of senior management experience including COO, CFO and CEO in several private and publicly traded corporations in manufacturing, mining exploration, consumer goods and entertainment. Mr. Useche is a CPA, CMA and a graduate of the executive MBA program at Queen’s University School of Business. Mr. Useche is also a graduate of the Corporate Directors program at the University of Toronto’s Rotman School of Business and of the Masters Certificate program in Risk Management program at York University’s Schulich School of Business.
Director and Chairman
Andre Godin is currently Executive Vice-President & Chief Financial Officer at IntelGenx and has more than 25 years’ experience in the Biotech-Pharma industry. He has a strong background in Capital Markets, Finance and Operations. Mr. Godin held several high level positions as CEO, CFO and Vice-President of pharmaceutical and nutraceutical Companies. Mr. Godin is a member of the Canadian Chartered Professional Accountants and the Canadian Institute of Chartered Accountants. He holds a Bachelor of Business Administration degree from Université du Québec à Montreal.
Leena Lakdawala is a senior executive with 22 years’ experience in the manufacturing and consumer product sector. Leena has served in several senior managerial roles in private and publicly held corporations, including Director of Administration, Director of Marketing, Vice-President of Operations and most recently Executive Vice-President. Leena serves on the board of several privately held companies and serves as an advisor to an early stage business venture. Leena is a graduate Executive MBA from Queens School of Business.
Michel currently holds the position of Head of Strategic Development at Neptune. He has been employed by Neptune since 2010, but was a member of the Board of Directors from 2000 to 2008. Mr. Timperio has many years of experience in sales. He obtained his Bachelor of Commerce at Concordia University in Montreal, Quebec. With a natural entrepreneurial character, he launched his own distributing business. Many years later, Mr. Timperio built a start-up venture in residential construction from 2001–2010. He has worked for large corporations, including Armstrong World Industries and Reichhold Chemicals, where he held senior management business development positions. Mr. Timperio has also retained a political career for six years.
Kristine is Director of Marketing and Business Development at Prometic Life Sciences, joining the organization in 2014. Having worked in the pharmaceutical and biotechnology industry for more than 17 years, Kristine has held senior positions in licensing, acquisitions, marketing and sales with geographical scope encompassing both North American and global markets. Acting in strategic leadership roles, Kristine has contributed to the successful launch of products in multiple therapeutic areas and has completed numerous due diligence evaluations as part of pipeline planning and expansion efforts to drive corporate growth. Kristine holds an MBA, BSc, CLP designation with CVA credential in progress.
Chief Financial Officer
Mr. William Waks, CPA, CA is a senior financial executive with experience with private and publicly traded companies. Mr. Waks served as Chief Financial Officer and Vice President of Finance at Osta Biotechnologies Inc. from June 2010 to April 2013 and prior to that period served as Consulting Chief Financial Officer of Osta Biotechnologies Inc. from June 20, 2007. Mr. Waks served as Chief Financial Officer of Copitrak Inc. (also known as Promatek Industries Ltd) from 2003 to 2007. He is a member of the Ordre des Comptable Agréés du Québec (1985) and the Ontario Institute of Chartered Accountants (1996). He obtained his designation after graduating from Concordia University (Bachelor of Commerce, 1982) and a diploma of public accountancy from McGill University’s Faculty of Graduate Studies and Research (1984).
Ted Zablotsky, MD
Ted Zablotsky, MD is co-founder and co-inventor of the US Patent acquired by the Company as part of the qualifying transaction of August 2015. Dr Zablotsky has pioneered research and documentation of the effects of bio-magnetism on the body since 1985. A noted author and speaker, Dr. Zablotsky has been a driving force beind the clinical development, research, and regulatory registrations that established the credibility of magnetic therapy. Dr. Zablotsky serves on the board of the Jewish Federation of Greater Hartford.